Developer docs
API playgroundTry for free, no card

Search company profiles

Erg Bio

Full company profile

uuid003qjrg

Namestring
Erg Bio
Legal namestring
Erg Bio, Inc.
Websiteurl
ergbio.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Erg Bio is a U.S.-based biomanufacturing company founded in 2023 and headquartered in Dublin, California, that develops and commercializes a proprietary biomass-to-products platform branded as Aspire™ Technology. The technology is a low-temperature solvent pretreatment and catalytic conversion system — exclusively licensed from Lawrence Berkeley National Laboratory's Joint BioEnergy Institute — that processes over 40 types of non-food biomass, including agricultural residues, forestry waste, municipal solid waste, dedicated energy crops, and mixed feedstocks, into fermentable sugars, intermediates, and drop-in fuels. Key technical claims include 90-95% sugar recovery (versus 75-80% for traditional methods), >98-99% solvent recycling, compatibility with commercially available industrial equipment, a proprietary engineered yeast that consolidates cellulase/hemicellulase production and sugar fermentation into a single step, and preservation of high-quality lignin for downstream valorization.

The intended end products are synthetic aviation fuels (SAF), bio-based chemicals, bioplastics, and lignin-derived materials. The business model is B2B enterprise technology licensing combined with future managed-services revenue from integrated biomanufacturing facilities and direct sales of biochemicals/intermediates. The go-to-market combines direct enterprise sales to major fuel and chemical companies with a parallel government-channel strategy targeting the U.S. Department of Defense Distributed Bioindustrial Manufacturing Program (DBIMP) and Department of Energy/EPA Inflation Reduction Act funding programs. The company has secured non-dilutive government awards — including a DoD DBIMP award (announced September 2024 as one of 12 awardees totaling $42M) and a $6M DOE/EPA IRA grant (January 2025) — and closed a $6.5 million seed round in November 2025 led by Azolla Ventures with participation from Chevron Technology Ventures, Freeflow, Plug and Play, and strategic angel investors. As of the available data, Erg Bio operates with a team of approximately 12, is pre-revenue, and is positioned at the pre-pilot demonstration stage of its commercialization roadmap.

Short descriptiontext

Erg Bio is a California-based biomanufacturing company that licenses and develops Aspire™ Technology, a proprietary low-temperature solvent pretreatment platform converting agricultural and forestry waste into fermentable sugars for synthetic aviation fuel and bio-based chemicals serving aviation, chemicals, and government customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDublin, United States
HQ citystring
Dublin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomass conversion technology, sustainable aviation fuel, bio-based chemicals, biomanufacturing platform, cellulosic feedstock processing
Industry2 codes
1Biofuel Plant EPC, O&M & Process Technology Providers
CodeEUAAAHAKPrimaryYes
2Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
CodeEUAAAIAAPrimaryNo
NAICS code2 codes
  • Chemical Manufacturing325
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomanufacturing / Biomass Conversion Technology
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Technology Licensing
TypeLicensing Royalties
Description

Licensing of Aspire™ Technology to industrial partners for production of synthetic aviation fuels and biochemicals from waste biomass

ergbio.com
2Biomanufacturing Facilities
TypeManaged Services
Description

Revenue from integrated biomanufacturing facilities producing fuels and chemicals, with estimated annual local economic impact of ~$100M per facility

ergbio.com
3Bio-based Chemicals Production
TypeHardware Sales
Description

Production and sale of cost-competitive biochemicals and intermediates derived from biomass conversion for industrial supply chains

ergbio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Erg Bio develops and licenses Aspire™ Technology, a proprietary low-temperature solvent pretreatment and catalytic platform that converts non-food biomass (agricultural residues, forestry waste, municipal solid waste) into fermentable sugars, high-value intermediates, and drop-in fuels such as synthetic aviation fuel and bio-based chemicals. The company monetizes through technology licensing to industrial partners and is positioned to deploy integrated biomanufacturing facilities producing fuels and chemicals at scale.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 90-95% sugar recovery vs traditional 75-80%
+5 more records
Product overview1 text field

Erg Bio offers a single unified product platform called Aspire™ Technology, a proprietary low-temperature solvent pretreatment and bioprocessing system that converts waste biomass into fermentable sugars and intermediates for synthetic aviation fuels and critical chemicals. The technology includes an advanced distillable solvent system that recycles over 99% of its components, combined with proprietary engineered yeast that hydrolyzes and ferments sugars, closing the loop from feedstock to finished product.

Product and service1 record
1Aspire™ Technology
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOthersAnnounced on2025-01-08
Description

Joint DOE/EPA program providing $6M in Inflation Reduction Act funding for demonstration of ASPIRE Feedstock Flexible Biomass Deconstruction and Conversion Technology at pre-pilot scale to advance sustainable aviation fuels.

Strategic tierCoreTypeTechnology or Integration
Description

Erg Bio's core technology is exclusively licensed from the deconstruction and advanced biofuels patent portfolio developed at DOE's Joint BioEnergy Institute, led by Lawrence Berkeley National Laboratory. This partnership provides the foundational IP for the Aspire™ Technology platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research and development partnership with the Integrated Bioresource Research Lab at University of Illinois for technology validation and advancement.

Strategic tierCoreTypeOthers
Description

Recipient of DoD Distributed Bioindustrial Manufacturing Program award. DoD supports domestic bioindustrial manufacturing for national security and defense industrial base resilience. Awards can provide access to up to $100M for facility construction.

Strategic tierCoreTypeOthers
Description

DOE's Bioenergy Technologies Office provides funding and support for advanced biofuels development. Erg Bio received $6M in Inflation Reduction Act funding for pre-pilot scale demonstration through DOE/EPA joint program.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sunfire develops power-to-liquid and biomass-to-liquid synthetic fuel technologies for e-fuels and SAF. Competes in the same renewable synthetic-fuels and bio-based chemicals space.

TypeDirect peer
Description

Velocys provides Fischer-Tropsch technology to convert biomass and waste feedstocks into SAF and synthetic fuels. Directly comparable as a biomass-to-fuels process technology company.

TypeDirect peer
Description

Iogen is a long-standing cellulosic-ethanol technology provider with proprietary enzyme and pretreatment platforms. Directly comparable as a biomass-to-fermentable-sugar process technology licensor.

TypeDirect peer
Description

Gevo develops renewable hydrocarbons and sustainable aviation fuel from biomass-derived intermediates. Targets the same aviation-fuel and bio-chemical end markets as Erg Bio with comparable feedstock-flexibility claims.

TypeBroad incumbent
Description

Praj Industries is a large incumbent process-technology and EPC provider for ethanol, biofuels, and biorefineries globally. Broad incumbent competing in the biofuel plant and process-technology space where Erg Bio's Aspire™ platform is positioned.

TypeEmerging player
Description

Bloom Biorenewables develops biomass valorization technology to produce specialty chemicals from lignin and cellulose. An emerging player in the same biomass-conversion space with a chemical-products focus comparable to Erg Bio's biochemical revenue stream.

TypeDirect peer
Description

Lanzajet converts ethanol (and potentially cellulosic sugars) into sustainable aviation fuel using Alcohol-to-Jet technology. A direct competitor in the cellulosic-SAF value chain that Erg Bio's Aspire™ platform could supply.

TypeDirect peer
Description

Aemetis develops renewable fuels including SAF and renewable diesel from biomass feedstocks. A directly comparable renewable-fuels producer targeting the same aviation and chemicals end markets.

TypeDirect peer
Description

LanzaTech uses proprietary gas-fermentation technology (comparable to Erg Bio's biomass-to-fuels platform) to convert waste gases and biomass into sustainable aviation fuel and chemicals. Operates a similar licensing/JV business model with major energy and industrial partners.

TypeDirect peer
Description

Virent (now part of Cargill) developed BioForming technology to convert plant sugars into drop-in biofuels and bio-based chemicals. A direct competitor in biomass-to-drop-in-fuels commercialization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Erg Bio

Biomanufacturing / Biomass Conversion Technologyergbio.com

Erg Bio is a California-based biomanufacturing company that licenses and develops Aspire™ Technology, a proprietary low-temperature solvent pretreatment platform converting agricultural and forestry waste into fermentable sugars for synthetic aviation fuel and bio-based chemicals serving aviation, chemicals, and government customers.

What Erg Bio does

Erg Bio is a U.S.-based biomanufacturing company founded in 2023 and headquartered in Dublin, California, that develops and commercializes a proprietary biomass-to-products platform branded as Aspire™ Technology. The technology is a low-temperature solvent pretreatment and catalytic conversion system — exclusively licensed from Lawrence Berkeley National Laboratory's Joint BioEnergy Institute — that processes over 40 types of non-food biomass, including agricultural residues, forestry waste, municipal solid waste, dedicated energy crops, and mixed feedstocks, into fermentable sugars, intermediates, and drop-in fuels. Key technical claims include 90-95% sugar recovery (versus 75-80% for traditional methods), >98-99% solvent recycling, compatibility with commercially available industrial equipment, a proprietary engineered yeast that consolidates cellulase/hemicellulase production and sugar fermentation into a single step, and preservation of high-quality lignin for downstream valorization.

The intended end products are synthetic aviation fuels (SAF), bio-based chemicals, bioplastics, and lignin-derived materials. The business model is B2B enterprise technology licensing combined with future managed-services revenue from integrated biomanufacturing facilities and direct sales of biochemicals/intermediates. The go-to-market combines direct enterprise sales to major fuel and chemical companies with a parallel government-channel strategy targeting the U.S. Department of Defense Distributed Bioindustrial Manufacturing Program (DBIMP) and Department of Energy/EPA Inflation Reduction Act funding programs. The company has secured non-dilutive government awards — including a DoD DBIMP award (announced September 2024 as one of 12 awardees totaling $42M) and a $6M DOE/EPA IRA grant (January 2025) — and closed a $6.5 million seed round in November 2025 led by Azolla Ventures with participation from Chevron Technology Ventures, Freeflow, Plug and Play, and strategic angel investors. As of the available data, Erg Bio operates with a team of approximately 12, is pre-revenue, and is positioned at the pre-pilot demonstration stage of its commercialization roadmap.

Erg Bio firmographics

Firmographics
Name
Erg Bio
Legal name
Erg Bio, Inc.
Website
https://ergbio.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Erg Bio is a California-based biomanufacturing company that licenses and develops Aspire™ Technology, a proprietary low-temperature solvent pretreatment platform converting agricultural and forestry waste into fermentable sugars for synthetic aviation fuel and bio-based chemicals serving aviation, chemicals, and government customers.
Ownership category
akta.pro rank

Erg Bio industry classification

Industry
Product category
Biomanufacturing / Biomass Conversion Technology
NAICS
Chemical Manufacturing (325), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Biofuel Plant EPC, O&M & Process Technology Providers (EUAAAHAK)
akta.pro secondary industry
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA)

Keywords

  • Biomass conversion technology
  • Sustainable aviation fuel
  • Bio-based chemicals
  • Biomanufacturing platform
  • Cellulosic feedstock processing

Where Erg Bio is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Erg Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Technology Licensing: Licensing of Aspire™ Technology to industrial partners for production of synthetic aviation fuels and biochemicals from waste biomass
  2. Biomanufacturing Facilities: Revenue from integrated biomanufacturing facilities producing fuels and chemicals, with estimated annual local economic impact of ~$100M per facility
  3. Bio-based Chemicals Production: Production and sale of cost-competitive biochemicals and intermediates derived from biomass conversion for industrial supply chains

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Erg Bio product offering

Product offering

Core offering

Erg Bio develops and licenses Aspire™ Technology, a proprietary low-temperature solvent pretreatment and catalytic platform that converts non-food biomass (agricultural residues, forestry waste, municipal solid waste) into fermentable sugars, high-value intermediates, and drop-in fuels such as synthetic aviation fuel and bio-based chemicals. The company monetizes through technology licensing to industrial partners and is positioned to deploy integrated biomanufacturing facilities producing fuels and chemicals at scale.

Product overview

Erg Bio offers a single unified product platform called Aspire™ Technology, a proprietary low-temperature solvent pretreatment and bioprocessing system that converts waste biomass into fermentable sugars and intermediates for synthetic aviation fuels and critical chemicals. The technology includes an advanced distillable solvent system that recycles over 99% of its components, combined with proprietary engineered yeast that hydrolyzes and ferments sugars, closing the loop from feedstock to finished product.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aspire™ Technology

Quantifiable outcome

  • 90-95% sugar recovery vs traditional 75-80%
  • +5 more outcomes

Companies that use Erg Bio

Customer profile

Segments4 records

Ideal customer profiles4 records

Erg Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Erg Bio partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • U.S. Environmental Protection AgencycoreOthers · 8 January 2025Joint DOE/EPA program providing $6M in Inflation Reduction Act funding for demonstration of ASPIRE Feedstock Flexible Biomass Deconstruction and Conversion Technology at pre-pilot scale to advance sustainable aviation fuels.
  • Lawrence Berkeley National Laboratory / Joint BioEnergy Institute (LBNL/JBEI)coreTechnology or IntegrationErg Bio's core technology is exclusively licensed from the deconstruction and advanced biofuels patent portfolio developed at DOE's Joint BioEnergy Institute, led by Lawrence Berkeley National Laboratory. This partnership provides the foundational IP for the Aspire™ Technology platform.
  • IBRL, University of IllinoiscoreStrategic or Co-development PartnerResearch and development partnership with the Integrated Bioresource Research Lab at University of Illinois for technology validation and advancement.
  • U.S. Department of DefensecoreOthersRecipient of DoD Distributed Bioindustrial Manufacturing Program award. DoD supports domestic bioindustrial manufacturing for national security and defense industrial base resilience. Awards can provide access to up to $100M for facility construction.
  • U.S. Department of EnergycoreOthersDOE's Bioenergy Technologies Office provides funding and support for advanced biofuels development. Erg Bio received $6M in Inflation Reduction Act funding for pre-pilot scale demonstration through DOE/EPA joint program.

Scale indicators10 records

Recent moves5 records

Expansion highlights6 records

Erg Bio competitors and assessment

Company assessment

Direct peers

  • Sunfire: Sunfire develops power-to-liquid and biomass-to-liquid synthetic fuel technologies for e-fuels and SAF. Competes in the same renewable synthetic-fuels and bio-based chemicals space.
  • Velocys: Velocys provides Fischer-Tropsch technology to convert biomass and waste feedstocks into SAF and synthetic fuels. Directly comparable as a biomass-to-fuels process technology company.
  • Iogen: Iogen is a long-standing cellulosic-ethanol technology provider with proprietary enzyme and pretreatment platforms. Directly comparable as a biomass-to-fermentable-sugar process technology licensor.
  • Gevo: Gevo develops renewable hydrocarbons and sustainable aviation fuel from biomass-derived intermediates. Targets the same aviation-fuel and bio-chemical end markets as Erg Bio with comparable feedstock-flexibility claims.
  • Lanzajet: Lanzajet converts ethanol (and potentially cellulosic sugars) into sustainable aviation fuel using Alcohol-to-Jet technology. A direct competitor in the cellulosic-SAF value chain that Erg Bio's Aspire™ platform could supply.
  • Aemetis: Aemetis develops renewable fuels including SAF and renewable diesel from biomass feedstocks. A directly comparable renewable-fuels producer targeting the same aviation and chemicals end markets.
  • LanzaTech: LanzaTech uses proprietary gas-fermentation technology (comparable to Erg Bio's biomass-to-fuels platform) to convert waste gases and biomass into sustainable aviation fuel and chemicals. Operates a similar licensing/JV business model with major energy and industrial partners.
  • Virent (Cargill): Virent (now part of Cargill) developed BioForming technology to convert plant sugars into drop-in biofuels and bio-based chemicals. A direct competitor in biomass-to-drop-in-fuels commercialization.

Broad incumbents

  • Praj Industries: Praj Industries is a large incumbent process-technology and EPC provider for ethanol, biofuels, and biorefineries globally. Broad incumbent competing in the biofuel plant and process-technology space where Erg Bio's Aspire™ platform is positioned.

Emerging players

  • Bloom Biorenewables: Bloom Biorenewables develops biomass valorization technology to produce specialty chemicals from lignin and cellulose. An emerging player in the same biomass-conversion space with a chemical-products focus comparable to Erg Bio's biochemical revenue stream.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Erg Bio social profiles

Digital presence

Erg Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Erg Bio leadership team

Management profile

Number of profiles

Profiles9 records

Erg Bio funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Erg Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Erg Bio

What does Erg Bio do?

Erg Bio develops and licenses Aspire™ Technology, a proprietary low-temperature solvent pretreatment and catalytic platform that converts non-food biomass (agricultural residues, forestry waste, municipal solid waste) into fermentable sugars, high-value intermediates, and drop-in fuels such as synthetic aviation fuel and bio-based chemicals. The company monetizes through technology licensing to industrial partners and is positioned to deploy integrated biomanufacturing facilities producing fuels and chemicals at scale.

Is Erg Bio a public or private company?

Erg Bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Erg Bio founded?

Erg Bio was founded in 2023. It employs 11 to 50 people.

Where is Erg Bio based?

Erg Bio is headquartered in Dublin, United States, in the North America region.

How does Erg Bio make money?

Three revenue lines are on record. Technology Licensing is the primary driver. The others are biomanufacturing Facilities and bio-based Chemicals Production.

Who are Erg Bio's main competitors?

Direct peers on record are Sunfire, Velocys, Iogen, Gevo, Lanzajet, Aemetis, LanzaTech and Virent (Cargill). Praj Industries is listed as a broad incumbent. Bloom Biorenewables is listed as an emerging player.

Does Erg Bio have an API?

No public API is recorded for Erg Bio.

What industry is Erg Bio in?

Erg Bio's product category is Biomanufacturing / Biomass Conversion Technology. Its primary akta.pro industry code is EUAAAHAK, Biofuel Plant EPC, O&M & Process Technology Providers, with a secondary code of EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 325 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupSeekerStartupSeekerErg Bio is a startup founded in 2023 that has developed Aspire™ Technology, a low-temperature solvent pretreatment process that converts diverse cellulosic waste streams including agricultural, forestry, and municipal solid waste into biochemicals, biomaterials, bioplastics, and sustainable aviation fuel. The technology is feedstock-agnostic, capable of processing over 30 different biomass sources, even in mixtures, and has been exclusively licensed from Lawrence Berkeley National Lab's Joint BioEnergy Institute. The company has demonstrated the technology at pilot scale using mixed feedstocks.GlobeNewswireErg Bio Closes $6.5 Million Seed Round to Scale Flexible Feedstock Technology for Manufacturing Synthetic Aviation Fuels and Critical ChemicalsErg Bio announced the closing of a $6.5 million seed round led by Azolla Ventures, with participation from Chevron Technology Ventures, Freeflow, Plug and Play, and strategic angel investors. The funding will be used to scale the company's Aspire™ Technology, a proprietary low-temperature pretreatment and catalytic platform that converts agricultural and forestry waste into intermediates for synthetic aviation fuels and critical bio-based chemicals. The technology builds on foundational research from Lawrence Berkeley National Laboratory's Joint BioEnergy Institute and is feedstock-flexible, operating with over 30 different biomass types.YahooErg Bio Closes $6.5 Million Seed Round to Scale Flexible Feedstock Technology for Manufacturing Synthetic Aviation Fuels and Critical ChemicalsErg Bio closed a $6.5 million seed round led by Azolla Ventures, with Chevron Technology Ventures and Freeflow participating. The funding will scale its Aspire technology, which converts agricultural and forestry wastes into synthetic aviation fuels and chemicals. The company plans to advance toward pilot-scale demonstrations.Advanced BioFuels USAAdvanced BioFuels USA – What’s New in Biofuels? Trends in Biofuel StartupsThe American Energy Society analyzed data on 70 university-affiliated startups in the biofuels sector, identifying key trends such as the prevalence of circular economy and carbon capture pairings. The study highlights that the United States dominates this innovation landscape with 52 startups, led by California, while emphasizing high-intrigue companies focused on waste-to-fuel technologies like Erg Bio and Raven SR. These findings suggest a market concentrating around carbon-circular solutions with scalable, modular architectures.IratrackerDOE & EPA Announce $6 Million to Support Development of Advanced BiofuelsThe U.S. Department of Energy and the Environmental Protection Agency announced $6 million in funding for three advanced biofuel projects on January 8, 2025. The grants support research into sustainable aviation fuel, biomass deconversion technology, and ethanol production by Air Company Holdings, Erg Bio Inc., and Terragia Biofuels respectively. This initiative aligns with the EPA’s Renewable Fuel Standard program and utilizes resources appropriated under IRA section 60108.